Home › Funds › Franklin Resources › DNLI
Franklin Resources position in DNLI
DENALI THERAPEUTICS INC · Health Care
Latest position (Q2 2026)56.66K sh
Reported value held$1.46M
Portfolio Weight0.00%
First reportedQ4 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2021 | 8.25K | $368.00K | New |
| Q3 2023 | 59.35K | $1.22M | New |
| Q4 2023 | 53.20K | $1.14M | Reduce |
| Q1 2024 | 50.59K | $1.04M | Reduce |
| Q2 2024 | 77.14K | $1.79M | Add |
| Q3 2024 | 80.04K | $2.15M | Add |
| Q4 2024 | 74.86K | $1.53M | Reduce |
| Q1 2025 | 83.25K | $1.13M | Add |
| Q2 2025 | 64.53K | $902.71K | Reduce |
| Q3 2025 | 64.63K | $938.49K | Hold |
| Q4 2025 | 60.27K | $995.06K | Reduce |
| Q1 2026 | 48.73K | $935.65K | Reduce |
| Q2 2026 | 56.66K | $1.46M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding DNLI
- BlackRock Inc 14.03M sh · $360.76M · Q2 2026
- Baillie Gifford & Co 11.96M sh · $307.62M · Q2 2026
- Vanguard Group 13.06M sh · $215.59M · Q4 2025
- Temasek Holdings 7.01M sh · $180.37M · Q2 2026
- Fidelity Management & Research (FMR) 4.54M sh · $116.66M · Q2 2026
- Goldman Sachs Group 4.16M sh · $106.89M · Q2 2026
- Geode Capital Management 3.97M sh · $102.21M · Q2 2026
- UBS Group AG 3.12M sh · $80.26M · Q2 2026
- Norges Bank Investment Management 2.82M sh · $72.65M · Q2 2026
- Capital Research Global Investors 2.57M sh · $65.99M · Q2 2026
- Casdin Capital 2.04M sh · $52.60M · Q2 2026
- Principal Global Investors 1.42M sh · $36.52M · Q2 2026